Neogen Chemicals Q1 FY27: Profit, Revenue, Guidance

Key takeaway from the quarter

Neogen Chemicals reported a strong start to FY27, with revenue growth, margin expansion and higher profits on both standalone and consolidated bases. The quarter was also marked by operational updates tied to the Dahej SEZ plant rebuild after the March 2025 fire incident. Management commentary pointed to record performance in organolithium and battery chemicals, and highlighted ongoing capacity expansion projects.

Standalone results: profit up 36%, revenue up 37%

For the quarter ended June 30, 2026, Neogen Chemicals reported standalone net profit of ₹19.44 crore, a 36.6% year-on-year increase from ₹14.23 crore in Q1 FY25. Standalone revenue from operations rose 36.7% to ₹252.28 crore compared with ₹184.58 crore a year earlier.

The company attributed the improvement to a stronger operational recovery following the fire incident at its Dahej SEZ plant in March 2025. The standalone numbers indicate that the business has moved past the disruption phase and is reporting growth on a year-on-year base.

Consolidated performance: revenue up 34%, PAT up 67%

On a consolidated basis, Neogen reported revenue of ₹250.29 crore, up 34.1% year-on-year. Consolidated profit after tax rose 67.0% to ₹17.11 crore.

In the earnings call dated July 27, 2026, the company reiterated consolidated revenue of ₹250 crore (also cited as “revenue from operations stood at ₹250 crore”) and highlighted that growth was driven by volume gains across core business verticals, sustained customer demand, and the “highest-ever quarterly revenue” in organolithium and battery chemicals.

EBITDA growth and margin expansion

The company reported consolidated EBITDA of ₹48 crore, a 53% year-on-year increase. EBITDA margin expanded by 260 basis points to 19.3%.

Management also flagged cost and operating factors in the quarter, including global supply chain volatility, elevated shipping freight costs, and temporary overheads linked to interim toll manufacturing arrangements. Despite these items, the company reported higher profitability and improved margins.

Business mix: organic, inorganic and Ionics

Neogen’s quarterly segment split provided in the call showed a divergence between organic and inorganic performance. Organic Chemicals revenue stood at ₹194 crore, reflecting 18% growth, while Inorganic Chemicals revenue surged 158% to ₹57 crore.

Neogen Ionics was also highlighted as a fast-growing unit. Neogen Ionics delivered ₹19 crore revenue in Q1 FY27, compared with ₹5 crore in Q1 FY26. Management noted that this was “over 50% of the entire previous year’s revenue” generated in one quarter.

Dahej rebuild, insurance recoveries and claim receivables

The company said the Dahej plant reconstruction is complete, providing an important operational milestone after the March 2025 incident. On insurance, the company disclosed cumulative insurance recoveries of ₹164 crore and a net claim receivable of ₹186 crore on a consolidated basis.

These disclosures matter for investors tracking cash flows and the extent to which insurance proceeds offset the financial impact of the disruption and rebuild.

Fundraising: board-approved QIP proposal

Neogen’s board approved a proposed QIP fundraise of ₹600 crore, subject to shareholder and regulatory approvals. In the call, management linked the fundraising plan to future growth opportunities and also referred to deleveraging.

Given the capital requirements of specialty chemicals and battery materials expansion, investors typically track such fundraises for timing, end-use and balance sheet impact.

Guidance and outlook points mentioned

Management commentary in the provided material included multiple guidance references:

• FY27 guidance was raised, with the battery business expected to contribute ₹300 crore and the base business expected to surpass ₹1,000 crore.
• A separate market summary of the call stated that management raised standalone base-business revenue guidance for FY27 to ₹950 million to ₹1.05 billion (equivalent to ₹95 crore to ₹105 crore), from ₹875 million to ₹950 million (equivalent to ₹87.5 crore to ₹95 crore), and said it expects to cross ₹1 billion (equivalent to ₹100 crore) in the current financial year.

The company also said major battery materials capex projects remain on track.

Market reaction and estimates snapshot

A market note stated the stock was little changed after the results, trading at ₹2,064.1, up 0.06% from the previous close of ₹2,062.8.

The same note said earnings per share were 6.00 versus a 3.63 forecast (a surprise of 65.29%), while it referenced revenue of ₹230 crore against a ₹231 crore estimate. Alongside this, the earnings call and consolidated disclosure highlighted quarterly revenue around ₹250 crore.

Key numbers at a glance

Timeline and corporate actions

Why this quarter matters

Neogen’s Q1 FY27 results combine three investor-relevant signals in one period: growth in revenue, improved operating margins, and a clearer view of post-disruption normalization after the Dahej incident. The segment split also points to strong momentum in inorganic chemicals, while management repeatedly linked performance to organolithium and battery chemicals.

The combination of insurance recoveries, remaining claim receivables, and a proposed QIP adds balance-sheet context for how the company plans to fund expansion while managing leverage. Investors will also watch follow-through on battery materials capex timelines and any further disclosures tied to the QIP process, including shareholder and regulatory milestones.

Conclusion

Neogen Chemicals reported higher Q1 FY27 profit and revenue, along with consolidated margin expansion to 19.3% and strong growth in key segments including inorganic chemicals and Neogen Ionics. The company said the Dahej reconstruction is complete, disclosed insurance recoveries and claim receivables, and referenced a ₹600 crore QIP proposal for future growth. The next set of updates is expected through subsequent financial disclosures and any formal progress on the QIP approvals and ongoing capex execution.